- Frederick National Lab
-
Research & Technology
-
Science Areas
-
AIDS and Cancer Virus Program
- Program Overview
- Sections
- Cores
- Basic Science Program
- Bioinformatics and Computational Science
- Cancer Research Technology Program
- Laboratory Animal Sciences Program
- Vaccine, Immunity, and Cancer Directorate
-
AIDS and Cancer Virus Program
-
Clinical Trial Support
-
Applied and Developmental Research Directorate
- Program Overview
-
Clinical Services Program
- AIDS Monitoring Laboratory
- Bioprocessing Laboratory
- Blood Processing Core
- Clinical Support Laboratory
- Flow Cytometry Support Laboratory
- Immunological Monitoring Laboratory
- Laboratory of Human Retrovirology and Immunoinformatics
- Laboratory of Molecular Cell Biology
- Neutrophil Monitoring Laboratory
- Radiochemistry Program
- Virus Isolation and Serology Laboratory
-
DCTD Support
- Cancer Imaging Informatics Laboratory
- Clinical Pharmacodynamics - Biomarkers Program
- In Vitro Evaluation and Molecular Pharmacology Laboratories
- In Vivo Evaluation Program
- Investigative Toxicology Laboratory
- NExT Chemical Biology Consortium Support Programs
- Natural Products Support Group
- Pharmacokinetics and Drug Analysis Group
- Radiochemistry Support Group
- Biopharmaceutical Development Program
- Clinical Monitoring Research Program
- Clinical Research Directorate
- Vaccine Clinical Materials Program
-
Applied and Developmental Research Directorate
-
Science Areas
-
Innovation & Initiatives
-
Initiatives
-
RAS Initiative
- Program Overview
- Biochemistry & Biophysics Research Team
- Bioinformatics Research Team
- Chemistry Research Team
- Computational Chemistry Research Team
- Drug Screening and Preclinical Research Team
- Imaging Research Team
- Mass Spectrometry Research Team
- Reagents Research Team
- Structural Biology Research Team
- Scientific Standards Hub
-
RAS Initiative
-
Innovation
Importance of innovation Within FNL, innovation plays a pivotal role in delivering new and enhanced technologies that empower us to tackle essential scientific inquiries, enhance our services, and ultimately contribute to the wellbeing of patients.Vladimir Popov, Ph.D., MBA
-
Scientific Series
- Biotech Connector
- High Fidelity
- Life Sciences Symposium
- RAS Initiative Symposium
- Scientific Partners Distinguished Lecture Series
- Technology Showcase
- Women in Science Speak
-
Initiatives
-
Investigator Resources
- All Resources
-
Data & Repositories
- BRB Preclinical Biologics Repository
- MHL Immunohistochemistry Database
- RAS Reagents & Tools
- dbGuide
- sgRNA Scorer
- More Repositories
-
National Scientific User Facilities
-
Training & Education
- cGMP Training
- FNL Global Clinical Research Educational Modules
- Project Management Night Out Seminar Series
-
Technical Services
- Program Overview
-
HIV/SIV Services
- Cellular or Tissue SIV/SHIV RNA and DNA testing
- HIV/SIV Single Genome Amplification and Sequencing
- Lineage-specific Next Gen Multiplex In Situ Hybridization for HIV or SIV RNA and DNA
- Next-generation sequencing analysis of barcoded SIV, SHIV, or HIV
- Novel CD4+ T Cell Specific Immunohistochemistry Detection and Analysis
- Plasma or CSF SIV/SHIV RNA measurements
- Quantitative Assessment of Lymphoid Tissue Fibrosis
- Quantitative assessment of HIV or SIV viral DNA in laser capture microdissected immune cells
- Viral Integration Site Analysis (VISA) for HIV studies
- Nanomedicine & Nanoformulation
- Other
-
Universal Standards & Reference Materials
- AI and Data Science
- Antibody Science
- Biospecimen Assays
- Biopharmaceutical Development
- Electron Microscopy
- Serology Operating Procedures
- Human SARS-CoV-2 Serology Standard
- Nanotechnology
- Protein Science
-
Work With Us
-
Collaboration
-
Tech Transfer & Licensing
- Vendors & Subcontractors
-
Collaboration
-
Careers
Brilliant teamwork The team here is made up of brilliant scientists. Coming from a diverse research background myself, it’s inspiring to be in a room where everyone contributes something unique. I feel truly privileged to be part of it.
Samarth Mathur, Ph.D. -
About FNL
Did you know?Biopharmaceutical Development Program manufactures CAR T-cell treatment for NCI phase 1 pediatric clinical trials.